Business Insider1mon
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight ... in North America, while LAL procedures account for over 10% of the region’s premium IOL market. We believe this sustained ...
Nasdaq1mon
RxSight, Inc. Reports Strong Preliminary Financial Results for Q4 and Full Year 2024, Provides 2025 Revenue Guidance
RxSight, Inc., an ophthalmic ... % of cataract surgeons in North America, while LAL procedures account for over 10% of the region’s premium IOL market. We believe this sustained growth in ...
Business Insider1mon
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients ...
Mena FN1mon
Rxsight, Inc. Announces Preliminary Unaudited Fourth Quarter And Full-Year 2024 Financial And Operational Results And 2025 Guidance
“During the fourth quarter, we achieved record highs for LDD sales and LAL procedures ... the RxSight system, that we believe will continue to set the standard for the premium IOL market ...
Yahoo Finance1mon
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical ... % of cataract surgeons in North America, while LAL procedures account for over 10% of the region’s premium ...